Literature DB >> 16869752

Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors.

R Pardal1, A V Molofsky, S He, S J Morrison.   

Abstract

Networks of proto-oncogenes and tumor suppressors that control cancer cell proliferation also regulate stem cell self-renewal and possibly stem cell aging. Proto-oncogenes promote regenerative capacity by promoting stem cell function but must be balanced with tumor suppressor activity to avoid neoplastic proliferation. Conversely, tumor suppressors inhibit regenerative capacity by promoting cell death or senescence in stem cells. For example, the polycomb family proto-oncogene, Bmi-1, is consistently required for the self-renewal of diverse adult stem cells, as well as for the proliferation of cancer cells in the same tissues. Bmi-1 promotes stem cell self-renewal partly by repressing the expression of Ink4a and Arf, tumor suppressor genes that are commonly deleted in cancer. Despite ongoing Bmi-1 expression, Ink4a expression increases with age, potentially reducing stem cell frequency and function. Increased tumor suppressor activity during aging therefore may partly account for age-related declines in stem cell function. Thus, networks of proto-oncogenes and tumor suppressors have evolved to coordinately regulate stem cell function throughout life. Imbalances within such networks cause cancer or premature declines in stem cell activity that resemble accelerated aging.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16869752     DOI: 10.1101/sqb.2005.70.057

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  58 in total

1.  Lnk constrains myeloproliferative diseases in mice.

Authors:  Alexey Bersenev; Chao Wu; Joanna Balcerek; Jiang Jing; Mondira Kundu; Gerd A Blobel; Kudakwashe R Chikwava; Wei Tong
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

Review 2.  Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.

Authors:  Satish Kalari; Gerd P Pfeifer
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

Review 3.  MYC as a regulator of ribosome biogenesis and protein synthesis.

Authors:  Jan van Riggelen; Alper Yetil; Dean W Felsher
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

Review 4.  The epigenetics of epithelial-mesenchymal plasticity in cancer.

Authors:  Wai Leong Tam; Robert A Weinberg
Journal:  Nat Med       Date:  2013-11-07       Impact factor: 53.440

5.  Bmi-1, stem cells and prostate carcinogenesis.

Authors:  David Moscatelli; E Lynette Wilson
Journal:  Asian J Androl       Date:  2011-02-21       Impact factor: 3.285

6.  βTrCP regulates BMI1 protein turnover via ubiquitination and degradation.

Authors:  Anagh A Sahasrabuddhe; Manjari Dimri; Prashant V Bommi; Goberdhan P Dimri
Journal:  Cell Cycle       Date:  2011-04-15       Impact factor: 4.534

7.  Nuclear magnetic resonance detects phosphoinositide 3-kinase/Akt-independent traits common to pluripotent murine embryonic stem cells and their malignant counterparts.

Authors:  Hanna M Romanska; Stefano Tiziani; Rachael C Howe; Ulrich L Günther; Zulfiqar Gulzar; El-Nasir Lalani
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

8.  CORRELATION PURSUIT: FORWARD STEPWISE VARIABLE SELECTION FOR INDEX MODELS.

Authors:  Wenxuan Zhong; Tingting Zhang; Yu Zhu; Jun S Liu
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2012-04-12       Impact factor: 4.488

9.  A functional screen for regulators of CKDN2A reveals MEOX2 as a transcriptional activator of INK4a.

Authors:  Jeffrey T Irelan; Ana Gutierrez Del Arroyo; Abel Gutierrez; Gordon Peters; Kim C Quon; Loren Miraglia; Sumit K Chanda
Journal:  PLoS One       Date:  2009-04-02       Impact factor: 3.240

Review 10.  Senescence induction; a possible cancer therapy.

Authors:  Matilde E Lleonart; Ana Artero-Castro; Hiroshi Kondoh
Journal:  Mol Cancer       Date:  2009-01-08       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.